Deepika Pakianathan
Director, Alexza Pharmaceuticals Inc.
Companies
- Freenome, Inc.Board member Jul 27, 2026 to now1
- Mereo BioPharma Group plcBoard member Jan 2, 2024 to now2
- Theravance Biopharma, Inc.Board member Jul 6, 2020 to now3
- Karyopharm Therapeutics Inc.Board member Nov 5, 2013 to now4
- Calithera Biosciences, Inc.Board member Oct 1, 2014 to Jan 31, 20235
- PARDES BIOSCIENCES, INC.Board member Feb 16, 2021 to Dec 30, 20216
- Disc Medicine, Inc.Board member Aug 11, 2020 to Aug 11, 20207
- OncoMedBoard member Jul 17, 2013 to Apr 23, 20198
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Freenome, Inc. FRNM13,918 shares9$171.5K at $12.32Jul 27, 2026
- Karyopharm Therapeutics Inc. KPTI15,508 shares10$5.4K at $0.35May 21, 2026
- Calithera Biosciences, Inc.0 shares11Jan 27, 2023
- Theravance Biopharma, Inc. TBPH0 shares12Sep 23, 2026
- Mereo BioPharma Group plc MREO0 shares13Aug 22, 2024
- PARDES BIOSCIENCES, INC.30,000 shares14Dec 23, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 23, 2026Returned to company 6,009 shares of Theravance Biopharma, Inc.12
- Sep 23, 2026Returned to company 58,065 shares of Theravance Biopharma, Inc.12
- Jun 12, 2026Granted 6,009 shares of Theravance Biopharma, Inc.15
- May 21, 2026Granted 15,508 shares of Karyopharm Therapeutics Inc.10
- May 19, 2025Granted 10,649 shares of Theravance Biopharma, Inc.16
- Aug 22, 2024Sold 105,244 shares at $4.43 of Mereo BioPharma Group plc13
- Aug 22, 2024Exercised options 2,071 shares at $3.87 of Mereo BioPharma Group plc13
- Aug 22, 2024Exercised options 43,485 shares at $0.94 of Mereo BioPharma Group plc13
- Aug 22, 2024Exercised options 38,953 shares at $1.31 of Mereo BioPharma Group plc13
- Aug 22, 2024Exercised options 12,418 shares at $2.72 of Mereo BioPharma Group plc13
- Aug 22, 2024Exercised options 6,492 shares at $1.84 of Mereo BioPharma Group plc13
- Aug 22, 2024Exercised options 1,825 shares at $3.00 of Mereo BioPharma Group plc13
- Jun 7, 2024Sold 2,240 shares at $0.95 of Karyopharm Therapeutics Inc.17
- Jun 7, 2024Sold 229,308 shares at $0.95 of Karyopharm Therapeutics Inc.17
- Jun 6, 2024Sold 1,145 shares at $0.98 of Karyopharm Therapeutics Inc.17
- Jun 6, 2024Sold 117,307 shares at $0.98 of Karyopharm Therapeutics Inc.17
- Jun 5, 2024Sold 4,526 shares at $0.96 of Karyopharm Therapeutics Inc.17
- Jun 5, 2024Sold 463,518 shares at $0.96 of Karyopharm Therapeutics Inc.17
- Jun 4, 2024Sold 3,298 shares at $0.95 of Karyopharm Therapeutics Inc.18
- Jun 4, 2024Sold 337,742 shares at $0.95 of Karyopharm Therapeutics Inc.18
- Jun 3, 2024Sold 3,488 shares at $1.00 of Karyopharm Therapeutics Inc.18
- Jun 3, 2024Sold 357,256 shares at $1.00 of Karyopharm Therapeutics Inc.18
- May 31, 2024Sold 1,976 shares at $0.95 of Karyopharm Therapeutics Inc.18
- May 31, 2024Sold 202,418 shares at $0.95 of Karyopharm Therapeutics Inc.18
- May 8, 2024Granted 10,537 shares of Theravance Biopharma, Inc.19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARFreenome, Inc., Board member
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARDisc Medicine, Inc., Board member
- 8SEC EDGAROncoMed, Board member
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARForm 4 filed Jun 16, 2026
- 16SEC EDGARForm 4 filed May 21, 2025
- 17SEC EDGARForm 4 filed Jun 7, 2024
- 18SEC EDGARForm 4 filed Jun 4, 2024
- 19SEC EDGARForm 4 filed May 10, 2024